Focused Ultrasound Surgery Foundation Announces Speakers, Moderators and Panelists for 2nd International Symposium on MR-Guided Focused Ultrasound
CHARLOTTESVILLE, Va., June 25 /PRNewswire-USNewswire/ -- Leading research and clinical experts from around the world are scheduled to speak at the 2nd International Symposium for MR-guided Focused Ultrasound, which will be held October 17 to 20 in the Washington, D.C. area.
In an announcement today, the Focused Ultrasound Surgery Foundation said that more than three dozen speakers, moderators and discussion panelists have been confirmed to date. The roster will expand significantly when the general and late-breaking abstract selection processes conclude in September.
A landmark event, the symposium will spotlight leading edge preclinical, translational and clinical research related to one of today's most promising and innovative therapeutic technologies. Targeted to scientists, clinicians and others interested in current and future applications of MR-guided focused ultrasound, the conference will offer a multifaceted exploration of this emerging field and feature plenary sessions, panel discussions, poster presentations and technical exhibits.
The program's dynamic structure is designed to foster the communication, cooperation and collaboration needed to accelerate the development and adoption of this nascent technology as a standard of patient care worldwide.
Symposium topics include:
- MR-guided focused ultrasound technology
- Brain applications
- Prostate applications
- Breast applications
- Liver applications
- Back and neck pain, other applications
- Uterine fibroids
- Bone tumors
- Focused ultrasound-mediated targeted drug delivery
- Late-breaking Research
- Focused Ultrasound Vendor Profiles
- Accelerating Development & Adoption
- Training and Credentialing
Keynote speakers for the symposium are:
- Kullervo Hynynen, Ph.D., a distinguished physicist and pioneer in the therapeutic use of focused ultrasound who holds appointments at the University of Toronto and at Sunnybrook Health Sciences Centre in Toronto. Dr. Hynynen is also honorary president of the symposium. He will present the David and Diane Heller Lecture, "Focused Ultrasound from an historical perspective."
- Laurent Leksell, Ph.D., M.B.A., an internationally known entrepreneur and business executive who founded Gamma Knife maker, Elekta, AB in Stockholm. Dr. Leksell will present the Batten Family Lecture, "Challenges in achieving the adoption of a disruptive technology."
Confirmed speakers, session moderators and discussion panelists include:
- Linda Bradley, M.D., Department of Obstetrics and Gynecology, Cleveland Clinic, Cleveland
- William Bradley, M.D., Ph.D., Department of Radiology, University of California, San Diego
- David Brenin, M.D., Department of Surgery, University of Virginia, Charlottesville
- Haywood Brown, M.D., Department of Obstetrics and Gynecology, Duke University Medical Center, Durham
- Falko Busse, Ph.D., Philips Healthcare, Vantaa
- Paul Chipperton, M.B.A., Profound Medical, Inc., Toronto
- Rajiv Chopra, Ph.D., Imaging Research, Sunnybrook Health Sciences Centre, Toronto
- Lawrence Crum, Ph.D., Acoustics and Electromagnetics Department, University of Washington, Seattle
- Erik Dumont, Ph.D., Image Guided Therapy, Pessac
- Rebecca Emerick, M.B.A., InSightec, Dallas
- Dieter Enzmann, M.D., Department of Radiology, University of California, Los Angeles
- Katherine Ferrara, Ph.D., Department of Biomedical Engineering, University of California, Davis
- Mathias Fink, Ph.D., Institut Langevin, French Institute for Health & Medical Research, Paris
- Hidemi Furusawa, M.D., Breast Surgical Oncology, Breastopia Namba Hospital, Tokyo
- Wladyslaw Gedroyc, M.D., Department of Interventional Magnetic Resonance Imaging, St. Mary's Hospital, London
- Gail ter Haar, Ph.D., Joint Department of Physics, Institute of Cancer Research, London
- Heather Huff Simonin, M.B.A., Focused Ultrasound Surgery Foundation, Charlottesville
- Mark Hurwitz, M.D., Department of Radiation Oncology, Dana-Farber/Brigham & Women's Cancer, Center, Harvard Medical School, Boston
- Ferenc Jolesz, M.D., National Center for Image-Guided Therapy, Brigham & Women's Hospital, Boston
- Neal Kassell, M.D., Department of Neurosurgery, University of Virginia, Charlottesville
- Laurence Klotz, M.D., Sunnybrook Health Sciences Centre, Toronto
- King Li, M.D., M.B.A., The Methodist Hospital Research Institute, Houston
- Matthias Matzko, M.D., Amper Kliniken, AG, Dachau
- Elliot McVeigh, Ph.D., Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore
- Chrit Moonen, Ph.D., Imagerie Moleculaire et Fonctionnelle: de la Physiologie a la Therapie, University Victor Segalen, Bordeaux
- Dennis Parker, Ph.D., Utah Center for Advanced Imaging Research, Departments of Bioengineering & Radiology, University of Utah, Salt Lake City
- Raphael Pfeffer, M.D., Department of Radiation Oncology, Chaim Sheba Medical Center, Tel Hashomer
- Joy Polefrone, Ph.D., Focused Ultrasound Surgery Foundation, Charlottesville
- Mitchell Schnall, M.D., Department of Radiology, University of Pennsylvania, Philadelphia
- Daniel Schultz, M.D., Greenleaf Health, LLC, Washington, D.C.
- Jacques Souquet, Ph.D., Supersonic Imagine, Aix-en-Provence
- Laurel Sweeney, Office of Medical and Health Affairs, Philips Healthcare, Andover
- Mickael Tanter, Ph.D., Institut Langevin, French Institute for Health & Medical Research, Paris
- Clare Tempany, M.D., National Center for Image-Guided Therapy, Brigham & Women's Hospital, Boston
- Kobi Vortman, Ph.D., InSightec, Tirat Carmel
- Bradford Wood, M.D., Center for Interventional Oncology, National Institutes of Health, Bethesda
Complete information about registration, abstract submission and accommodations for the 2nd International Symposium on MR-guided Focused Ultrasound can be found at http://www.fusfoundation.org/Symposium.
About the Focused Ultrasound Surgery Foundation
Founded in 2006 and based in Charlottesville, Virginia, the Focused Ultrasound Surgery Foundation is dedicated to accelerating research and development of patient treatments using one of today's most revolutionary and promising medical technologies: MR-guided focused ultrasound (FUS). The Foundation's work is motivated by the belief that FUS treatments could become the ultimate in noninvasive surgery, serve as a viable alternative to radiation therapy and offer a new platform for precise drug delivery - applications with the potential to alleviate suffering, save lives and quicken recovery times for millions of patients worldwide.
By promoting communication, collaboration and coordination, the Foundation has become a vital nexus for researchers, clinicians, manufacturers, philanthropists and other stakeholders in the FUS arena. The Foundation is funding translational and clinical research, providing fellowships for training physicians and scientists, hosting symposia and workshops, maintaining online informational resources and establishing FUS Centers of Excellence. Complete information about the Foundation and its work can be found at http://fusfoundation.org
This news release was issued on behalf of Newswise(TM). For more information, visit http://www.newswise.com.
Related medicine technology :1
|SOURCE Focused Ultrasound Surgery Foundation|
Copyright©2010 PR Newswire.
All rights reserved
. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-882
. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX3
. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting4
. Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Dont Vaccinate5
. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium6
. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri7
. Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection8
. Leading AIDS Groups Turn Up The Heat on 08 Presidential Candidates9
. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents10
. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist11
. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent